ArticleAnnals of surgical oncology2025
Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting: Breast Cancer Treatment Disparities.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Socio-Demographic Inequalities in Diagnostic Delays of Breast Cancer: A Multistage Time-to-Diagnosis Analysis.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence-based benchmarks have been established to assess the quality of breast cancer care, as delays in treatment correlate with poor clinical outcomes. Our aim was to identify factors influencing the timeliness of care within a rural East Texas healthcare system. PATIENTS AND
methodsPatients diagnosed with invasive breast cancer were identified and monitored from January 2015 to October 2022. Timeliness of care was assessed retrospectively across three intervals: diagnostic imaging to biopsy, biopsy to surgical treatment, and mammogram to surgical treatment. We analyzed correlations between demographic and clinical factors influencing timely initiation of treatment in our population against recommendations from the National Consortium of Breast Centers (NCBC).
resultsA total of 278 cases were included over the 5-year study period. Nearly half met the recommended timeline from diagnostic imaging to biopsy, 13.3% from mammogram to surgical treatment, and 10.3% from biopsy to surgical treatment. A delay in the "diagnostic imaging to biopsy" interval or "biopsy to surgical treatment" interval predicted delays in the mammogram to treatment interval. Hispanics were more likely to present with stage 3 cancer and had a 4.5 times higher likelihood of mortality compared with Non-Hispanic whites.
conclusionsDelay in one phase of care predicted delays in subsequent phases. Timeliness of treatment also influenced survival rates among Hispanic patients. Understanding factors influencing the timeliness of breast cancer treatment may guide targeted interventions in the future for patients at greater risk of care delays.
Indexed as
Identifiers
40246744What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.